Cell Growth & Differentiation, Vol 6, Issue 6 655-663, Copyright © 1995 by American Association of Cancer Research

ARTICLES

Growth inhibition and apoptosis of RL human B lymphoma cells by vitamin E succinate and retinoic acid: role for transforming growth factor beta

JM Turley, S Funakoshi, FW Ruscetti, J Kasper, WJ Murphy, DL Longo and MC Birchenall-Roberts
Laboratory of Leukocyte Biology, National Cancer Institute, Frederick, Maryland 21702, USA.

Vitamin E succinate (VES) and all-trans-retinoic acid (RA) were determined to be growth inhibitory for B lymphoma cells in vitro. RL, an Epstein-Barr virus-negative human cell line, was growth suppressed 87% with VES (5 micrograms/ml) and 58% with RA (10(-6) M); both agents blocked the cells in G1 of the cell cycle. The antiproliferative effect of VES seems to be independent of its potential antioxidant property because both fat- and water-soluble antioxidants were found to have no effect on RL cell proliferation. VES and RA increased IgM antibody concentrations in cell supernatants 5.8- and 9.9-fold, respectively. DNA fragmentation and flow cytometry studies showed VES- and RA-induced apoptosis in RL cells. VES- and RA-treated RL cells gradually underwent apoptosis over time with maximal induction occurring at days 6 and 5 of culture, respectively. A role for transforming growth factor beta in VES- and RA-mediated RL growth suppression is indicated by increased ligand and type II receptor protein expression. Furthermore, neutralizing antibodies to transforming growth factor beta 1 partially blocked the growth suppressive action of both VES and RA, thus suggesting that a TGF-beta autocrine negative loop was involved in VES and RA suppression of RL cell growth.

This article has been cited by other articles:

				M. Shim and T. E. Eling Vitamin E succinate induces NAG-1 expression in a p38 kinase-dependent mechanism Mol. Cancer Ther., April 1, 2008; 7(4): 961 - 971. [Abstract] [Full Text] [PDF]

				S. Donapaty, S. Louis, E. Horvath, J. Kun, S. M. Sebti, and M. P. Malafa RRR-{alpha}-Tocopherol succinate down-regulates oncogenic Ras signaling. Mol. Cancer Ther., February 1, 2006; 5(2): 309 - 316. [Abstract] [Full Text] [PDF]

				M. Stapelberg, N. Gellert, E. Swettenham, M. Tomasetti, P. K. Witting, A. Procopio, and J. Neuzil {alpha}-Tocopheryl Succinate Inhibits Malignant Mesothelioma by Disrupting the Fibroblast Growth Factor Autocrine Loop: MECHANISM AND THE ROLE OF OXIDATIVE STRESS J. Biol. Chem., July 8, 2005; 280(27): 25369 - 25376. [Abstract] [Full Text] [PDF]

				M. A. Murtaugh, K.-n. Ma, J. Benson, K. Curtin, B. Caan, and M. L. Slattery Antioxidants, Carotenoids, and Risk of Rectal Cancer Am. J. Epidemiol., January 1, 2004; 159(1): 32 - 41. [Abstract] [Full Text] [PDF]

				A. Dutta and S. K. Dutta Vitamin E and its Role in the Prevention of Atherosclerosis and Carcinogenesis: A Review J. Am. Coll. Nutr., August 1, 2003; 22(4): 258 - 268. [Abstract] [Full Text] [PDF]

				K. N. Prasad, B. Kumar, X.-D. Yan, A. J. Hanson, and W. C. Cole {alpha}-Tocopheryl Succinate, the Most Effective Form of Vitamin E for Adjuvant Cancer Treatment: A Review J. Am. Coll. Nutr., April 1, 2003; 22(2): 108 - 117. [Abstract] [Full Text]

				R. Brigelius-Flohe, F. J Kelly, J. T Salonen, J. Neuzil, J.-M. Zingg, and A. Azzi The European perspective on vitamin E: current knowledge and future research Am. J. Clinical Nutrition, October 1, 2002; 76(4): 703 - 716. [Abstract] [Full Text] [PDF]

				A. K. Pathak, N. Singh, N. Khanna, V. G. Reddy, K. N. Prasad, and V. Kochupillai Potentiation of the Effect of Paclitaxel and Carboplatin by Antioxidant Mixture on Human Lung Cancer H520 Cells J. Am. Coll. Nutr., October 1, 2002; 21(5): 416 - 421. [Abstract] [Full Text] [PDF]

				H. You, W. Yu, B. G. Sanders, and K. Kline RRR-{alpha}-Tocopheryl Succinate Induces MDA-MB-435 and MCF-7 Human Breast Cancer Cells to Undergo Differentiation Cell Growth Differ., September 1, 2001; 12(9): 471 - 480. [Abstract] [Full Text] [PDF]

				K. Kline, W. Yu, and B. G. Sanders Vitamin E: Mechanisms of Action as Tumor Cell Growth Inhibitors J. Nutr., January 1, 2001; 131(1): 161S - 163. [Full Text]

				K. Woodson, J. A. Tangrea, M. J. Barrett, J. Virtamo, P. R. Taylor, and D. Albanes Serum {alpha}-Tocopherol and Subsequent Risk of Lung Cancer Among Male Smokers J Natl Cancer Inst, October 20, 1999; 91(20): 1738 - 1743. [Abstract] [Full Text] [PDF]

				W. Yu, K. Israel, Q. Y. Liao, C. M. Aldaz, B. G. Sanders, and K. Kline Vitamin E Succinate (VES) Induces Fas Sensitivity in Human Breast Cancer Cells: Role for Mr 43,000 Fas in VES-triggered Apoptosis Cancer Res., February 1, 1999; 59(4): 953 - 961. [Abstract] [Full Text] [PDF]

				G. Wu, R. S. Fan, W. Li, V. Srinivas, and M. G. Brattain Regulation of Transforming Growth Factor-beta Type II Receptor Expression in Human Breast Cancer MCF-7 Cells by Vitamin D3 and Its Analogues J. Biol. Chem., March 27, 1998; 273(13): 7749 - 7756. [Abstract] [Full Text] [PDF]

				G.-R. Han, D. F. Dohi, H.-Y. Lee, R. Rajah, G. L. Walsh, W. K. Hong, P. Cohen, and J. M. Kurie All-trans-retinoic Acid Increases Transforming Growth Factor-beta 2 and Insulin-like Growth Factor Binding Protein-3 Expression through a Retinoic Acid Receptor-alpha -dependent Signaling Pathway J. Biol. Chem., May 23, 1997; 272(21): 13711 - 13716. [Abstract] [Full Text] [PDF]